8-KEarnings & ResultsRegulation FDExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Jul 26, 2024)

Filed July 26, 2024For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) has filed an 8-K report on July 26, 2024, to announce its financial results for the second quarter of 2024. The report primarily references an Earnings Press Release and a related Investor Presentation, both dated July 26, 2024, which contain detailed financial and operational information. Investors should refer to these furnished documents for a comprehensive understanding of the company's performance during the quarter. The company has made these materials available on its website and through a conference call and webcast. It's important for investors to note that both the press release and presentation include non-GAAP financial information. The company has provided reconciliations between non-GAAP and GAAP measures within the Earnings Press Release, along with explanations for the use of these non-GAAP figures. Investors are advised to review these reconciliations and the company's official filings for complete financial transparency.

Key Highlights

  • 1BMY filed an 8-K on July 26, 2024, to report Q2 2024 financial results.
  • 2Key financial and operational details are provided in an Earnings Press Release (Exhibit 99.1).
  • 3An Investor Presentation (Exhibit 99.2) offering further insights into financial and operating initiatives is also available.
  • 4Both the press release and presentation contain non-GAAP financial information.
  • 5Reconciliations between non-GAAP and GAAP financial measures are available in the Earnings Press Release.
  • 6The furnished information is not deemed 'filed' under Section 18 of the Exchange Act, meaning it does not carry the same legal implications as traditional filings.
  • 7BMY hosted a conference call and webcast on July 26, 2024, to discuss the Q2 results and presentation.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce Bristol-Myers Squibb Company's financial results for the second quarter of 2024. It includes references to an Earnings Press Release and an Investor Presentation containing these results and other financial and operational information.

You can find the detailed Q2 2024 financial results in the Earnings Press Release, furnished as Exhibit 99.1 to this 8-K filing. An Investor Presentation (Exhibit 99.2) is also available, which should be read in conjunction with the press release.

Yes, both the Earnings Press Release and the Bristol Myers Presentation referenced in this filing contain non-GAAP financial information. The company has provided reconciliations between these non-GAAP measures and the comparable GAAP financial measures within the Earnings Press Release.

The information furnished in this 8-K, including the press release and presentation, is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities associated with such filings and is not automatically incorporated by reference into future filings, unless specifically stated otherwise.